The expression of S100A4, EMP3, and PLAUR was increased in recurrent gliomas compared with primary gliomas (Supplementary Figures S1A–C) as were the risk scores of recurrent gliomas (Supplementary Figure S1D). The gene discussed is S100A4; the disease is central nervous system cancer.